CORASANTI EUGENE R

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
53
Insider Sells Sum
$35.86M

Insider Activity of CORASANTI EUGENE R

The largest sale of all time was on 2012-03-13 and amounted to 112500 shares of CONMED Corporation for $2.91M.

Biography of CORASANTI EUGENE R

No biography is available at this moment.

2013-11-20SaleCONMED Corporation
CNMD
director
20,000
0.0656%
$34.54$690,754+13.04%
2013-01-04SaleCONMED Corporation
CNMD
director
43,408
0.1453%
$26.57$1.15M+17.67%
2013-01-03SaleCONMED Corporation
CNMD
director
780
0.0028%
$28.10$21,918+18.41%
2013-01-02SaleCONMED Corporation
CNMD
director
52,833
0.1676%
$25.03$1.32M+18.26%
2012-12-12SaleCONMED Corporation
CNMD
director
146
0.0005%
$26.57$3,878+19.34%
2012-09-10SaleCONMED Corporation
CNMD
director
37,922
0.1272%
$26.28$996,469+14.1%
2012-09-07SaleCONMED Corporation
CNMD
director
35,882
0.1262%
$27.51$986,967+14.1%
2012-09-06SaleCONMED Corporation
CNMD
director
26,196
0.0881%
$26.28$688,550+14.17%
2012-03-13SaleCONMED Corporation
CNMD
director
112,500
0.3548%
$25.89$2.91M-3.48%
2011-10-28SaleCONMED Corporation
CNMD
director
10,649
0.0383%
$26.12$278,197+7.72%
2011-03-03SaleCONMED Corporation
CNMD
director
24,732
0.087%
$26.43$653,667-0.28%
2011-03-02SaleCONMED Corporation
CNMD
director
5,268
0.0186%
$26.07$137,337+1.76%
2008-08-28SaleCONMED Corporation
CNMD
director
61,096
0.2117%
$32.00$1.96M-47.37%
2008-08-15SaleCONMED Corporation
CNMD
director
2,400
0.0083%
$32.00$76,800-47.4%
2008-08-14SaleCONMED Corporation
CNMD
director
23,797
0.0826%
$32.02$761,913-47.31%
2008-02-26SaleCONMED Corporation
CNMD
director
64,481
0.2257%
$27.83$1.79M-7.78%
2008-02-25SaleCONMED Corporation
CNMD
director
10,419
0.0364%
$27.57$287,243-6.9%
2008-02-22SaleCONMED Corporation
CNMD
director
100
0.0004%
$27.50$2,750-6.52%
2008-02-21SaleCONMED Corporation
CNMD
director
25,000
0.0872%
$27.63$690,805-7.21%
2007-05-22SaleCONMED Corporation
CNMD
director
3,925
0.0139%
$31.00$121,675-11.81%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.